Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively introduce a pediatric ABA therapy company for sale in New Jersey. The company provides center-based ABA Therapy services, rooted in naturalistic, play-based programming and supported by a purpose built, Artificial Intelligence enabled technology stack to drive outsized scale. Since its inception, the company has grown into a market-leading provider with strong payer relationships, robust clinical outcomes, and a proven framework for de novo expansion.

Payer Mix and Patient Demographic

The company’s payer mix is 90% MCO/Medicaid and 10% commercial insurance. The company is credentialed with most major carriers, such as Aetna, Horizon BCBS, Cigna, Humana, United Healthcare, NJ Family Care, Magellan, Optum, and Magellan. They only serve pediatric patients.

Financial Overview

The company has developed and implemented a proven market penetration strategy, supported by attractive de novo unit economics, that will continue to drive growth in both existing and new states. Their de novo experience has allowed them to develop a “model center” with consistent metrics and a predictable growth trajectory.

The company has developed and implemented a proven market penetration strategy, supported by attractive de novo unit economics, that will continue to drive growth in both existing and new states. Their de novo experience has allowed them to develop a “model center” with consistent metrics and a predictable growth trajectory.

They have enjoyed explosive growth, reaching nearly $1.4 million in 2024. They continue to grow their census at an intentionally steady pace, and they grossed over $1.73 million with an adjusted EBITDA of $408,921. The goal is to ramp up to 32 clients (max capacity) in 2026, at which point their run rate will be $3 million with an adjusted EBITDA of $500,000.

Through 2025, the company was focused solely on full time clients, or those with at least 35 – 40 hours per week. In 2026, they will start taking on part-time clients, which is expected to conservatively boost annual revenue by $600,000 – $800,000, based on the existing local demand and waitlist.

Staff Overview and Exit Plan

The staff consists of a full spectrum of clinical leadership, certified clinicians and highly-trained administrative support, all of whom are expected to stay on under new ownership. Current ownership is not involved in the day-to-day operations and is focused on other endeavors. They would consider maintaining an advisory role with the company.

Asking Price

The sellers are seeking a buyer who sees the value in the infrastructure they have built and desires to continue scaling the business. They are seeking a price of $1.5 million and are open to a deal that includes rollover equity and an earn out, as they are confident and invested in the company’s ongoing success.